Found: 20
Select item for more details and to access through your institution.
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 530, doi. 10.1007/s10637-020-01031-z
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 3, p. 181, doi. 10.1159/000490949
- By:
- Publication type:
- Article
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1841, doi. 10.1007/s10147-022-02241-6
- By:
- Publication type:
- Article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090929
- By:
- Publication type:
- Article
Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3521, doi. 10.1111/1759-7714.13695
- By:
- Publication type:
- Article
Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1699, doi. 10.1111/1759-7714.12884
- By:
- Publication type:
- Article
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
- By:
- Publication type:
- Article
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 791, doi. 10.1007/s00280-010-1382-1
- By:
- Publication type:
- Article
Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 5, p. 829, doi. 10.1007/s00280-007-0540-6
- By:
- Publication type:
- Article
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 267, doi. 10.1007/s00280-006-0369-4
- By:
- Publication type:
- Article
Patient satisfaction with sedation for flexible bronchoscopy.
- Published in:
- Respirology, 2008, v. 13, n. 5, p. 722, doi. 10.1111/j.1440-1843.2008.01311.x
- By:
- Publication type:
- Article
Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
- Published in:
- Psycho-Oncology, 2009, v. 18, n. 5, p. 483, doi. 10.1002/pon.1450
- By:
- Publication type:
- Article
Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 405, doi. 10.3892/mco.2014.252
- By:
- Publication type:
- Article